98%
921
2 minutes
20
Background: Late adverse reactions associated with the combined therapy of valproate and lamotrigine are infrequently documented within the Chinese population.
Case Presentation: This case report describes a 54-year-old female patient who developed adverse reactions following long-term therapy with valproate and lamotrigine, with symptoms emerging five months after the final adjustment of her antiseizure regimen. The patient presented with symptoms of dizziness, ataxia, nystagmus, and postural tremors. Following blood drug concentration monitoring and subsequent minor dosage adjustments to the antiseizure regimen without medication withdrawal, the patient's symptoms were successfully resolved.
Conclusions: This article underscores the importance of vigilance among clinicians regarding the potential for late adverse reactions and advocates for the proactive monitoring of blood drug concentrations.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042444 | PMC |
http://dx.doi.org/10.1186/s42494-025-00217-3 | DOI Listing |
Neurol Med Chir (Tokyo)
September 2025
Department of Neurosurgery, Tokyo Medical University.
Adhesive materials are widely used in microvascular decompression for treating neurovascular compression syndromes. They play an important role in the critical step of vessel fixation. Recently, completely autologous fibrin glue produced solely from a patient's own plasma was developed.
View Article and Find Full Text PDFYakugaku Zasshi
September 2025
Kampo Research Laboratories, Pharmaceutical Company, Kracie, Ltd.
Dysmenorrhea refers to pathological symptoms that occur in association with menstruation during the menstrual period. Treatment options for dysmenorrhea include nonsteroidal anti-inflammatory drugs (NSAIDs) and low-dose estrogen-progestin combination pills. However, some patients do not respond to these treatments, and long-term use can lead to adverse reactions, raising additional problems.
View Article and Find Full Text PDFLancet Rheumatol
September 2025
University of Otago Christchurch, Christchurch, New Zealand; Christchurch Hospital, Health New Zealand Waitaha, Christchurch, New Zealand.
Lancet Rheumatol
September 2025
Academic Rheumatology, University of Nottingham, Nottingham, UK.
Background: Allopurinol, the most prescribed urate-lowering drug, is a known cause of severe cutaneous adverse reactions. We aimed to develop and validate a model to assess the risk of allopurinol-induced severe cutaneous adverse reactions in adults newly prescribed allopurinol.
Methods: In this retrospective new-user cohort study, we developed and validated a prognostic model using primary care, hospitalisation, and mortality data extracted from the UK Clinical Practice Research Datalink (CPRD) primary care database, for the period Jan 1, 2001, to March 29, 2021.
Explore (NY)
September 2025
Center of Children's Clinic, The Affiliated Hospital to Changchun University of Chinese Medicine, Jilin Changchun 130117, China. Electronic address:
Aim: This study evaluates the efficacy and safety of scalp acupuncture in treating tic disorders.
Methods: We conducted a meta-analysis using data from 19 randomized controlled trials (RCTs) involving 1463 patients, sourced from various databases up to May 16, 2023. Stata15.